Borderline Case: International Tax Policy, Corporate Research and Development, and Investment Contributor(s): National Research Council (Author), Board on Science Technology and Economic (Author), Poterba, James (Editor) |
|||
ISBN: 030906368X ISBN-13: 9780309063685 Publisher: National Academies Press
Binding Type: Paperback Published: February 1998 Annotation: Twelve leading tax analysts, practitioners, and policy makers examine the impact of U.S. international tax rules and incentives for research and development on the activities of U.S. and foreign-based firms. They consider how the income deferral and expense allocation rules, research and experimentation tax credit, and R&D expensing affect the level and location of corporate investment. Click for more in this series: U.S. Industry, Restructuring and Renewal |
Additional Information |
BISAC Categories: - Business & Economics | International - Taxation - Business & Economics | Taxation - Corporate - Business & Economics | Labor |
Dewey: 336.243 |
LCCN: 97045343 |
Series: U.S. Industry, Restructuring and Renewal |
Physical Information: 0.45" H x 6" W x 9.01" L (0.61 lbs) 168 pages |
Features: Index |
Review Citations: Ingram PTR 07/01/1999 pg. 5 |
Descriptions, Reviews, Etc. |
Publisher Description: The growing integration of world markets for capital and goods, coupled with the rise of instantaneous worldwide communication, has made identification of corporations as American, Dutch, or Japanese extremely difficult. Yet tax treatment does depend of where a firm is chartered. And, as Borderline Case documents, there is little doubt that tax rules for firms doing business in several nations?firms that account for more than three-quarters of corporate R&D spending in the United States?have substantial effects on corporate decisionmaking and, ultimately, U.S. competitiveness. This book explores the impact of the U.S. tax code and its incentives on the international activities of U.S.- and foreign-based firms: basic research outlays, expenditures on product and process development, and plant and equipment investment. The authors include industry experts from large multinational firms in technology and pharmaceuticals, academic researchers who have explored the quantitative impact of tax provisions on R&D, and tax policy analysts who have examined international tax rules in the broader context of tax reform. These experts look at how corporate investment and R&D are shaped by specific tax provisions, such as the definition of taxable income, relative tax burdens on domestic and foreign business, taxation of earnings repatriated to the United States, deductibility of expenses of worldwide operations, and U.S. corporate taxes relative to other countries. The volume explores prescriptions and prospects for tax reform and reviews major reform proposals and their implications for the behavior of multinational business. |
Customer ReviewsSubmit your own review |
To tell a friend about this book, you must Sign In First! |